examples of glp-1 receptor agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways The anti-inflammatory and immunological properties

Jill Corleone, RD Medical Reviewer Jill is a registered dietitian and health writer based in Honolulu

Given that PCOS is frequently comorbid with steatotic liver disease and hypertriglyceridemia, we recommend intensified screening for gallbladder symptoms (e.g., right upper quadrant pain, fatty food intolerance) and regular monitoring of hepatobiliary markers during phases of rapid weight loss

Pablo de la Cueva has participated as consultant and/or investigator and/or speaker for the following pharmaceutical companies: Abbvie, Almirall, BMS, Boehringer-Ingelheim, Celgene, Janssen Cilag, LEO Pharma, Lilly, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, and UCB

Making food choices feels easier and less overwhelming

Study participants We identified all adult (aged 20 years) patients with NAFLD and type 2 diabetes who had newly started treatment with non-insulin glucose-lowering drugs (metformin, GLP-1RAs, SGLT2 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, acarbose or dipeptidyl peptidase-4 inhibitors) between 1 January 2013 and 31 December 2021